Growing tissue stem cells into organoids and tumeroids: Predictive assay development

Colorectal cancer screening and the EORTC SPECTA initiative

EORTC fosters move towards tailored cancer treatment through the SPECTA initiative in colorectal cancer

Investigating anticarcinogenic compounds as an alternative to chemo

KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second-line treatment of mCC

Comment: CALGB/SWOG 80405 study on chemo combos in colorectal

ASCO 2014 roundup

Regorafenib shows early promise in colorectal candidates unable to undergo chemo

Genomic sequencing helps identify best candidates for adjuvant chemo in colorectal cancer

First-line bevacizumab plus chemo and cetuximab plus chemo provide similar survival benefits in metastatic colorectal cancer

First-line bevacizumab plus chemotherapy and cetuximab plus chemotherapy provide similar survival benefit for patients with metastatic colorectal cancer

Role of AORTIC in dealing with rising cancer rates in Africa